Stanisic, S., Bertolotto, A., Berto, P., Di Procolo, P., & Morawski, J. (2019). The cost-effectiveness of alemtuzumab in the management of relapse-remitting multiple sclerosis in Italy. Global and Regional Health Technology Assessment, 6(1). https://doi.org/10.33393/grhta.2019.465